Sorrento therapeutics stocktwits

Mar 9, 2007 · Sorrento is a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to treat cancers and COVID-19. Sorrento’s multimodal, …Find the latest Sorrento Therapeutics, Inc. (SRNE) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders ... meowbahhs address Kala Pharmaceuticals Inc. $32.13. $0.18. (0.56%) Cookie_M 25m. Stay focused. This time I'm gonna be away until the weekend. Won't reply to any posts until then. Use the …Jan 17, 2023 · Cambridge Investment Research Advisors Inc. increased its stake in shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE – Get Rating) by 11.2% during the third quarter, HoldingsChannel reports ...Find real-time SRNE - Sorrento Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. rite aid pfizer booster shot Jun 24, 2021 · Shares of Sorrento Therapeutics ( SRNE 3.02%) jumped 10.6% on Thursday. The big gain came after the company announced that its COVI-STIX COVID-19 rapid diagnostic test received an official... Jan 15, 2023 · Mirati Therapeutics (NASDAQ:MRTX - Get Rating) was upgraded by stock analysts at StockNews.com to a "sell" rating in a note issued to investors on Friday.Other equities analysts have also issued research reports about the stock. B. Riley began coverage on shares of Mirati Therapeutics in a research report on Friday, October 28th. … mucinex pregnancy hack SRNE Conversations From StockTwits Sorrento Therapeutics Inc. (SRNE) Social Stream SRNE Home News Ratings Charts Social Price Target Sorrento Therapeutics Inc. (SRNE): $0.89 0.03 (+3.02%) POWR Rating Component Grades Sign Up to See Ratings...FREE! We have 9 different ratings for every stock to help you appreciate its future potential.Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from ... SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that COVID-19 patients have been dosed in its Phase 2 efficacy trial. Approximately 350 outpatients with COVID-19 who are asymptomatic or have mild symptoms will be enrolled in this large double-blind, ... lowes rototiller rentalSorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the …Find the latest Sorrento Therapeutics, Inc. (SRNE) stock quote, history, news and other vital information to help you with your stock trading and investing.SRNE (Sorrento Therapeutics Inc) Stock Technical Analysis | 10/2/2021 - YouTube 0:00 / 2:47 #TechnicalAnalysis #StockCharts SRNE (Sorrento Therapeutics Inc) Stock Technical Analysis |... lotrimin cream walmart Sorrento Therapeutics, Inc. (NASDAQ: SRNE) is a San Diego-based, antibody-centric, commercial-stage biopharmaceutical concern focused on developing therapies for a wide spectrum of diseases ...Jan 12, 2023 · Sorrento Therapeutics is a clinical-stage biopharma company that operates in 2 segments. These are Sorrento Therapeutics and Scilex which is also a publicly listed company. Scilex is in the business of non-opioid pain relief and has recently had a product hit the market. The news here is that sales in 2022 were much better than expected. Sorrento Therapeutics - We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19 Jan 12, 2023 · Sorrento Therapeutics is a clinical-stage biopharma company that operates in 2 segments. These are Sorrento Therapeutics and Scilex which is also a publicly listed company. Scilex is in the business of non-opioid pain relief and has recently had a product hit the market. The news here is that sales in 2022 were much better than expected. Sorrento Therapeutics - We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19A high-level overview of Sorrento Therapeutics, Inc. (SRNE) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Shares of the small-cap cancer companies Adaptimmune Therapeutics (ADAP 2.19%), Agenus (AGEN 2.79%), and Sorrento Therapeutics (SRNE-5.04%) all rose by more than 5% during Tuesday's trading session. jdnews mugshots 2022 Sorrento Therapeutics, Inc. is an Equal Opportunity Employer and offers candidates an attractive salary and comprehensive benefits package that includes stock options, medical, dental, life and disability insurance, 401k and paid holidays. View Current Openingssorrento therapeutics wkn: a1w8dy isin: us83587f2020 wkn: a1w8dy isin: us83587f2020 steinholtz german shepherds 1 日前 ... Read Cambridge Investment Research Advisors Inc. Has $157000 Position in Sorrento Therapeutics, Inc. (NASDAQ:SRNE) at Defense World.Pronóstico del tiempo en Portelândia, Estado de Goiás, Brasil para hoy y esta noche, condiciones meteorológicas y radar Doppler de The Weather Channel y weather.comSorrento Therapeutics stock, a clinical stage biopharma company that develops treatments for cancer and neurodegenerative diseases among others, has fallen by 6 ... macos ventura beta 6 Jun 24, 2021 · Shares of Sorrento Therapeutics ( SRNE 3.02%) jumped 10.6% on Thursday. The big gain came after the company announced that its COVI-STIX COVID-19 rapid diagnostic test received an official... Assignee: Sorrento Therapeutics, Inc. Inventors: Russell F. Ross, Andrew T. Baker, Luke Hagan VARIANT ANTIBODIES THAT BIND OX40. Publication number: 20210395380 Abstract: The present disclosure provides variant anti-OX40 antibodies that mimic the activity of OX4OL by behaving as an agonist against receptor OX40 to enhance T cell clonal ...Find real-time SRNE - Sorrento Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. Find the latest Sorrento Therapeutics, Inc. (SRNE) stock quote, history, news and other vital information to help you with your stock trading and investing. hbo max 3 month trial Shares of Sorrento Therapeutics ( SRNE 3.02%) jumped 10.6% on Thursday. The big gain came after the company announced that its COVI-STIX COVID-19 rapid diagnostic test received an official...Find the latest Sorrento Therapeutics, Inc. (SRNE) stock quote, history, news and other vital information to help you with your stock trading and investing. mini cooper parking lamp malfunction SRNE | Complete Sorrento Therapeutics Inc. stock news by MarketWatch. View real-time stock prices and stock quotes for a full financial overview.Sorrento Acquires the Sofusa ™ Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics. Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ("Sorrento") announced today that it acquired the Sofusa™ lymphatic delivery technology platform from Kimberly-Clark Corporation ...Jan 15, 2023 · Mirati Therapeutics (NASDAQ:MRTX - Get Rating) was upgraded by stock analysts at StockNews.com to a "sell" rating in a note issued to investors on Friday.Other equities analysts have also issued research reports about the stock. B. Riley began coverage on shares of Mirati Therapeutics in a research report on Friday, October 28th. … wellsfargo comlogin Jan 17, 2023 · A high-level overview of Sorrento Therapeutics, Inc. (SRNE) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.Founded in 1989, Sorrento Therapeutics is a clinical-stage, antibody-centric, biopharmaceutical company developing new therapies to treat cancers. The company i Read More Headquarters 4955 Directors Pl, San Diego, California, 92121, United States Phone Number (858) 203-4100 Website www.sorrentotherapeutics.com Revenue $57M Stock Symbol SRNE marlin 30 30 age by serial number Find real-time SRNE - Sorrento Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.The Investor Relations website contains information about Sorrento Therapeutics's business for stockholders, potential investors, and financial analysts.Sorrento Therapeutics started at buy with $24 stock price target at Dawson James Securities. May. 26, 2020 at 7:30 a.m. ET by Tomi Kilgore. Investing Day Trading Has Replaced Sports Betting as ... astrotwins daily scorpio Find real-time SRNE - Sorrento Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. cpi training cpi restraint holds Sorrento Therapeutics - We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19Jan 12, 2023 · Sorrento Therapeutics is a clinical-stage biopharma company that operates in 2 segments. These are Sorrento Therapeutics and Scilex which is also a publicly listed company. Scilex is in the business of non-opioid pain relief and has recently had a product hit the market. The news here is that sales in 2022 were much better than expected.Find real-time SRNE - Sorrento Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. power wheels f150 Kala Pharmaceuticals Inc. $32.13. $0.18. (0.56%) Cookie_M 25m. Stay focused. This time I'm gonna be away until the weekend. Won't reply to any posts until then. Use the …Later Friday, Sorrento Therapeutics will announce their discovery of the STI-1499 antibody, which the San Diego company said can provide "100% inhibition" of COVID-19, adding that a treatment ... autonation subaru hours DiaMedica Therapeutics Inc Stock - DMAC Share Price Today, News and Discussion More Advertisement 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. DMAC DiaMedica Therapeutics Inc 1,374 $1.64 $0.02 (1.24%) Today $0.00 0.00 (0.00%) After Hours Sentiment N/A Message Vol. 0.00% Market Cap $42.84M Volume (M) 16,312.00 ups pro number Mar 9, 2007 · Sorrento is a clinical stage, antibody-centric, biopharmaceutical company developing new therapies to treat cancers and COVID-19. Sorrento’s multimodal, …Kala Pharmaceuticals Inc. $32.13. $0.18. (0.56%) Cookie_M 25m. Stay focused. This time I'm gonna be away until the weekend. Won't reply to any posts until then. Use the …Stocktwits is the largest social network for finance. Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Stocktwits is the largest social network for finance. Rooms Rankings Earnings Newsletters. Cancel. Log In. Sign Up. DOW 0.00%. S&P 500 0.00%. NASDAQ 0.00%. Trending now. #SORRENTO.2022/02/07 ... Biotech stocks have been some of the worst-performing equities over the past four months. Shares of Gritsone bio and Sorrento Therapeutics could ...Brokerages Set Sorrento Therapeutics Inc (NASDAQ:SRNE) Price Target at $21.00 Shares of Sorrento Therapeutics Inc (NASDAQ:SRNE) have been assigned an average recommendation of Hold from the six analysts that are currently covering the firm, MarketBeat Ratings reports. apple valley waste 2021 schedule 2 days ago · Sorrento Therapeutics is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Sorrento Therapeutics' performance …Sorrento Therapeutics, Inc. (SRNE) Stock Forum & Discussion - Yahoo Finance Sign in Mail Finance Home Watchlists My Portfolio Crypto Yahoo Finance Plus News Screeners Markets Videos Personal...Sorrento Therapeutics - We apply cutting-edge science to create innovative therapies that will improve the lives of those who suffer from cancer, intractable pain and COVID-19 Sorrento Therapeutics, Inc. Analyst Report: Moderna Inc Moderna Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of... ark dx10 sky too bright Oct 26, 2021 · Find the latest Sorrento Therapeutics, Inc. (SRNE) stock discussion in Yahoo Finance's forum. Share your opinion and gain insight from other stock traders and …Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from... Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from ... when will esporta open 24 hours Assignee: Sorrento Therapeutics, Inc. Inventors: Russell F. Ross, Andrew T. Baker, Luke Hagan VARIANT ANTIBODIES THAT BIND OX40. Publication number: 20210395380 Abstract: The present disclosure provides variant anti-OX40 antibodies that mimic the activity of OX4OL by behaving as an agonist against receptor OX40 to enhance T cell clonal ...Sorrento Therapeutics Inc (NASDAQ:SRNE) Quote Profile News Charts Forecasts Financials Shareholders Competitors Stock Price Forecast The 2 analysts offering 12-month price forecasts for Sorrento... ray eddington county commissioner About Sorrento Therapeutics (NASDAQ:SRNE) Stock Sorrento Therapeutics, Inc., a clinical stage and commercial biopharmaceutical company, develops therapies for cancer, autoimmune, inflammatory, viral, and neurodegenerative diseases. It operates through two segments, Sorrento Therapeutics and Scilex.How much institutional selling is happening at Sorrento Therapeutics? Institutional investors have sold a total of 15,726,779 shares in the last 24 months. This volume of shares sold represents approximately $89.86M in transactions. This page (NASDAQ:SRNE) was last updated on 1/14/2023 by MarketBeat.com Staff.Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Stocktwits is the largest social network for finance. Rooms Rankings Earnings Newsletters. Cancel. Log In. Sign Up. DOW 0.00%. S&P 500 0.00%. NASDAQ 0.00%. Trending now. #SRNE. Filter by: body rubs ashevilleView the latest Sorrento Therapeutics Inc. (SRNE) stock price, news, historical charts, analyst ratings and financial information from WSJ.Jan 12, 2023 · Prothena Co. plc (NASDAQ:PRTA - Get Rating) Director Shane Cooke sold 5,000 shares of the stock in a transaction that occurred on Tuesday, January 10th. The stock was sold at an average price of $52.92, for a total transaction of $264,600.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, …2021/06/24 ... The time is now… many of us on Stocktwits and other forums ... Sorrento Therapeutics, Inc., under the safe harbor provisions of Section university of tennessee fight song lyrics Dec 27, 2022 · Presently, Sorrento Therapeutics Inc. shares are logging -86.32% during the 52-week period from high price, and 10.05% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $0.74 and $5.92. Apr 26, 2021 · Shares of Sorrento Therapeutics ( SRNE 13.72%) are rising sharply on Monday and were up by 10.8% as of 1:43 p.m. EDT after jumping by as much as 14.6% earlier in the trading session. The ...Jan 14, 2023 · SAN DIEGO, March 31, 2022 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento"), announced today that the FDA has …Jan 18, 2023 · SAGE stock opened at $44.04 on Wednesday. The company has a fifty day moving average price of $39.17 and a 200-day moving average price of $38.67. The company has a market capitalization of $2.62 billion, a P/E ratio of -5.10 and a beta of 1.17. Sage Therapeutics, Inc. has a 52-week low of $27.36 and a 52-week high of $49.56. laramie wy obituaries Esperion Therapeutics, Inc. has a one year low of $3.28 and a one year high of $8.87. The stock's 50 day simple moving average is $6.68 and its 200 day simple moving average is $6.97. Esperion Therapeutics (NASDAQ:ESPR - Get Rating) last released its quarterly earnings results on Tuesday, November 1st. The biopharmaceutical company reported ($0 ...2022/02/07 ... Biotech stocks have been some of the worst-performing equities over the past four months. Shares of Gritsone bio and Sorrento Therapeutics could ...Jan 13, 2023 · of the 96 institutional investors that sold sorrento therapeutics stock in the last 24 months, the following investors and hedge funds have sold the highest volume of shares: ubs group ag ($2.25m), morgan stanley ($1.94m), cormorant asset management lp ($1.75m), rafferty asset management llc ($0.75m), sg americas securities llc ($0.56m), … cracker season 1 episode 3 cast Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Stocktwits is the largest social network for finance. Rooms …Sorrento Therapeutics Inc Stock - SRNE Share Price Today, News and Discussion Advertisement 3rd Party Ad. Not an offer or recommendation by Stocktwits. See disclosure here. SRNE Sorrento Therapeutics Inc 72,454 Watch $1.07 $0.02 (1.91%) Today Sentiment 0.29% Message Vol. 3.64% Market Cap $504.91M Volume (M) 24,095.00 52-Wk High $4.67 Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the evolution of cancer, from ... Jan 14, 2023 · Get Sorrento Therapeutics Inc (SRNE:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. ascension complete centene Kala Pharmaceuticals Inc. $32.13. $0.18. (0.56%) Cookie_M 25m. Stay focused. This time I'm gonna be away until the weekend. Won't reply to any posts until then. Use the …Sorrento Therapeutics, Inc. (SRNE) Stock Historical Prices & Data - Yahoo Finance Sorrento Therapeutics, Inc. (SRNE) NasdaqCM - NasdaqCM Real Time Price. Currency in USD Follow 2W 10W 9M 1.0500...Sorrento to Host Webcast to Discuss Newly Presented Clinical Data Demonstrating Significant Improvements in Therapeutic Outcomes in 10 of 10 Patients with Poorly Controlled Rheumatoid Arthritis ATLANTA and SAN DIEGO, Nov. 13, 2022 (GLOBE NEWSWIRE) -- Sofusa®, a wholly-owned division of Sorrento Therapeutics (Nasdaq: …Jan 17, 2023 · Cambridge Investment Research Advisors Inc. increased its stake in shares of Sorrento Therapeutics, Inc. ( NASDAQ:SRNE – Get Rating) by 11.2% during the third quarter, HoldingsChannel reports.... kidnapped by my mate galatea Jan 12, 2023 · Sorrento Therapeutics is a clinical-stage biopharma company that operates in 2 segments. These are Sorrento Therapeutics and Scilex which is also a publicly listed company. Scilex is in the business of non-opioid pain relief and has recently had a product hit the market. The news here is that sales in 2022 were much better than expected. A high-level overview of Sorrento Therapeutics, Inc. (SRNE) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. uc mass center Sorrento Therapeutics, Inc. Analyst Report: Moderna Inc Moderna Inc., a clinical stage biotechnology company, develops therapeutics and vaccines based on messenger RNA for the treatment of...Apr 26, 2021 · Shares of Sorrento Therapeutics ( SRNE 13.72%) are rising sharply on Monday and were up by 10.8% as of 1:43 p.m. EDT after jumping by as much as 14.6% …Sorrento Therapeutics, Inc. ClinicalTrials.gov Identifier: NCT05007418 Other Study ID Numbers: 38DART-RRMM-101 : First Posted: August 16, 2021 Key Record Dates: Last Update Posted: November 15, 2022 Last Verified: November 2022 Layout table for additional information ...Jan 17, 2023 · Cambridge Investment Research Advisors Inc. increased its stake in shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE – Get Rating) by 11.2% during the third quarter, HoldingsChannel reports ... avct sec filing +++Helm auf, steiler Anstieg! - Die große Analyse zu einer der spannendsten Uranaktien überhaupt +++Kala Pharmaceuticals Inc. $32.13. $0.18. (0.56%) Cookie_M 25m. Stay focused. This time I'm gonna be away until the weekend. Won't reply to any posts until then. Use the …Jan 12, 2023 · Sorrento Therapeutics is a clinical-stage biopharma company that operates in 2 segments. These are Sorrento Therapeutics and Scilex which is also a publicly listed company. Scilex is in the business of non-opioid pain relief and has recently had a product hit the market. The news here is that sales in 2022 were much better than expected. synonyms for bodily Sorrento Therapeutics Inc stock information & DD group. *We are not part of the Sorrento Therapeutics team* Created Jan 30, 2021. 3.5k. Members. 14. Online. r/srne Rules. 1. …Jun 24, 2021 · Shares of Sorrento Therapeutics ( SRNE 3.02%) jumped 10.6% on Thursday. The big gain came after the company announced that its COVI-STIX COVID-19 rapid diagnostic test received an official... Nov 14, 2022 · Sorrento Therapeutics Inc. 4955 Directors Place. San Diego, California 92121. Phone 1 858 203-4100. Industry Biotechnology. Sector Health Care/Life Sciences. It focuses on therapies to treat specific stages in the evolution of cancer, from elimination, to equilibrium and escape which include biosimilars, immuno- ...Apr 26, 2021 · Shares of Sorrento Therapeutics ( SRNE 13.72%) are rising sharply on Monday and were up by 10.8% as of 1:43 p.m. EDT after jumping by as much as 14.6% … grand rapids craigslist cars for sale by owner Jan 12, 2023 · Sorrento Therapeutics is a clinical-stage biopharma company that operates in 2 segments. These are Sorrento Therapeutics and Scilex which is also a publicly listed company. Scilex is in the business of non-opioid pain relief and has recently had a product hit the market. The news here is that sales in 2022 were much better than expected. Jan 17, 2023 · Cambridge Investment Research Advisors Inc. increased its stake in shares of Sorrento Therapeutics, Inc. (NASDAQ:SRNE – Get Rating) by 11.2% during the third quarter, HoldingsChannel reports ...Sorrento Therapeutics is a clinical-stage biopharma company that operates in 2 segments. These are Sorrento Therapeutics and Scilex which is also a publicly listed company. Scilex is in the business of non-opioid pain relief and has recently had a product hit the market. The news here is that sales in 2022 were much better than expected.Sorrento Acquires the Sofusa ™ Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics. Sorrento Therapeutics, Inc. (NASDAQ:SRNE) ("Sorrento") announced today that it acquired the Sofusa™ lymphatic delivery technology platform from Kimberly-Clark Corporation ... coast guard pt uniform SAN DIEGO, July 21, 2021 (GLOBE NEWSWIRE) -- Sorrento Therapeutics, Inc. (Nasdaq: SRNE, "Sorrento") today announced that COVID-19 patients have been dosed in its Phase 2 efficacy trial. Approximately 350 outpatients with COVID-19 who are asymptomatic or have mild symptoms will be enrolled in this large double-blind, ...Sorrento Therapeutics, Inc. engages in the research, development and manufacture of biopharmaceutical products. It focuses on therapies to treat specific stages in the …Join Stocktwits for free stock discussions, prices, and market sentiment with millions of investors and traders. Stocktwits is the largest social network for finance. Rooms … emporia energy home assistant Breakout Long Short Good short trade quality (tight cover, etc...) but neutral overall. Share page https://stockconsultant.com/?SRNE. Links SRNE StockTwits.Jul 21, 2021 · sorrento's commitment to life-enhancing therapies for patients is also demonstrated by our effort to advance a first-in-class (trpv1 agonist) non-opioid pain management small molecule, resiniferatoxin (“rtx”), and sp-102 (10 mg, dexamethasone sodium phosphate viscous gel) (semdexa™), a novel, viscous gel formulation of a widely used … cameron estate inn wedding cost sorrento therapeutics wkn: a1w8dy isin: us83587f2020 wkn: a1w8dy isin: us83587f2020Find real-time SRNE - Sorrento Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business.Aug 23, 2021 · After 12 weeks of receiving SOFUSA with Enbrel at 25 mg weekly, disease activity as measured by DAS28-ESR decreased 34.1% from 4.58 at Baseline to 3.02 at Week 12 demonstrating a change from ... malcolm in the middle netflix 2022. 8. 2. · Down from US$7.50, the current price target is an average from 4 analysts. New target price is 2,143% above last closing price of US$0.15. Stock is down 95% over the past year. The company is forecast to post a net loss per share of US$0.28 next year compared to a net loss per share of US$0.25 last year. Jul 23.Sorrento Therapeutics, Inc. has a 52-week low of $0.74 and a 52-week high of $4.58. Sorrento Therapeutics (NASDAQ:SRNE - Get Rating) last issued its earnings results on Tuesday, November 8th ...The stock price of Sorrento Therapeutics (NASDAQ: SRNE), a clinical stage biopharma company that develops treatments for cancer and neurodegenerative diseases among others, has seen a solid 49%... aetna silverscript choice pdp formulary 2022